[TL;DR: The market is paying up for scarcity. Last week, money rotated into metals, energy, biotech, space, and strategic infrastructure, while insider activity is at 0.34 buy/sell ratio, just under our strong-buy threshold and the highest it's been in months. Below, I break down the key names money flowed into and the insider-backed names that may be best positioned to follow.]

Last week’s tape did not behave like a market pricing in collapse.

It behaved like a market pricing in shortage.

That is the key distinction.

Across the insider tape, the average buy/sell ratio came in at 0.34. Your line for a strong buy signal is 0.35. So we are not talking about euphoric insider buying, but we are talking about a reading that is close enough to say insiders are still leaning constructive, not defensive. That matters because it tells us this rotation is happening in a market where smart money inside companies is not acting like a major air pocket is dead ahead.

And the macro backdrop helps explain why capital moved the way it did.

March payrolls surprised to the upside, which reduces the odds of the Fed rushing in with cuts. At the same time, the market is still dealing with war-related energy disruption, elevated oil, and supply chain uncertainty tied to the Strait of Hormuz. Reuters also reported aluminum hit a four-year high after attacks on major Middle East smelters deepened supply fears, while another Reuters report noted the White House moved ahead with a 100% tariff threat on branded drug imports unless pricing or production terms changed. In other words, this was a week where scarcity, security, and supply chains mattered more than broad beta.

That is why the winners were so revealing.

The biggest breadth came from metals and mining. The strongest story-stock action came from biotech. Defense and space kept attracting momentum capital. Energy stayed hot because oil stayed elevated. Then, underneath all of that, you saw selective moves in communications infrastructure, semis, and rate-sensitive financial names that suggest the market is still willing to speculate when it sees a clean catalyst.

This was not random.

This market is paying up for scarcity.

The clearest winning group was metals and mining.

Alcoa, Century Aluminum, SSR Mining, Aura Minerals, Aya Gold & Silver, Discovery Silver, Orla Mining, Agnico Eagle, First Majestic Silver, and Zhaojin Mining all show up as evidence that capital wanted hard-asset leverage. Some of these names are obvious aluminum or industrial-metal beneficiaries. Others are gold and silver names, which tells you the move broadened from a supply-shock trade into a wider real-asset trade.

The leadership inside that group also matters. Century Aluminum gained 29.3% on the week. Alcoa gained 24.2%. SSR Mining gained 28.1%. Aura Minerals gained 32.3%. These were not sleepy defensive upticks. This was aggressive buying in companies tied to physical scarcity, constrained supply, and hard assets with operating leverage.

If this theme is going to persist, the next thing to watch is simple: do aluminum, gold, and silver names continue to hold their breakouts even if the war headlines cool down? If they do, then this stops being a one-week geopolitical trade and starts becoming a broader repricing of scarce materials exposure.

The second major bucket was biotech.

Apellis Pharmaceuticals was the standout, up 129.1% in a single week. Centessa Pharmaceuticals gained 35.0%. Ascentage Pharma gained 28.3%. Soleno Therapeutics gained 24.0%. Relay Therapeutics gained 23.9%. Agios rose 17.5%. Erasca added 17.5%.

That kind of action tells you this was not just money hiding in defensives. It was money chasing idiosyncratic upside and clinical or product-specific repricing. But it is also where investors need to be most disciplined. Biotech can lead hard for a week and then hand back gains just as fast if the move was event-driven rather than the start of a sustained rerating.

The policy backdrop makes it even more interesting. The administration’s tariff threat on branded pharmaceuticals adds another layer of complexity for the group. Large global drug makers may have to navigate pricing and manufacturing pressure, while smaller and mid-cap innovators can still rip higher if they have company-specific catalysts. That means biotech strength is real, but it is not a simple, clean “buy the whole group” signal. It is a stock-picker’s tape.

The third bucket was defense and space.

York Space Systems gained 32.3%. Intuitive Machines gained 24.8%. Firefly Aerospace gained 22.8%. Hensoldt, Thales, RENK, and Planet Labs all participated.

That makes sense. Investors are still willing to pay for national-security exposure, orbital infrastructure, and defense-adjacent technology when the geopolitical backdrop stays unstable. Reuters also reported that anticipation around a SpaceX IPO helped lift aerospace shares, which likely added fuel to the move in names tied to the broader space ecosystem.

Here, the actionable question is not whether the story makes sense. It does.

The actionable question is whether the market keeps rewarding second-tier names after the first momentum burst. If York, Intuitive Machines, Firefly, and Planet Labs continue to attract sponsorship next week, then this theme is broadening. If they stall while only the highest-profile names hold up, then the trade is becoming more crowded and less forgiving.

The fourth bucket was energy and power.

PT Medco Energi gained 49.3%. PTT Exploration & Production gained 40.9%. Idemitsu Kosan gained 11.8%. Utilities and power-adjacent names also held up better than many would have expected, with names like Central Puerto, Entergy, Enagas, Orsted, Fortum, and Tokyo Electric all making appearances in the weekly winners list.

This tracks perfectly with the macro tape. Reuters reported that oil disruptions tied to the Iran conflict remained severe heading into the weekend, with benchmark crude still sharply elevated and supply constraints unresolved. When oil stays high and the market worries about reliability of fuel, transport, and power, capital naturally starts paying for energy exposure and for assets tied to electricity stability.

I do not think this is a place to chase blindly after a huge first move. But I do think it is a place to keep stalking names with either operating leverage to high commodity prices or strategic positioning in power resilience.

The fifth bucket was communications and orbital connectivity.

Globalstar gained 29.0%. Iridium rose 16.1%. EchoStar gained 15.6%. Ciena rose 15.4%. Lumentum gained 20.1%. Viasat added 12.2%.

This part of the tape is easy to miss if you are only staring at the oil chart. But it is important. When the market pays for satellite connectivity, optical infrastructure, and communications systems in the same week it pays for defense and space, it is telling you investors are thinking in systems, not just headlines. They are following the plumbing behind a more contested and capacity-constrained world.

That is worth respecting.

The sixth bucket was the rate-sensitive squeeze.

Fannie Mae gained 39.6%. Freddie Mac gained 31.1%. Uniti Group gained 31.5%. SBA Communications rose 22.8%. Even with rates not exactly cooperating, some beaten-up financial and real-estate-linked names caught strong bids.

This is the kind of move that usually tells you there is still plenty of speculation left in the tape. It is not my favorite macro signal, but it is a useful sentiment tell. A market that is completely shutting down does not usually hand out 30% to 40% weekly moves in these kinds of names.

Put all of those buckets together and the message gets clearer.

The market was not rewarding “cheap” in the abstract.

It was rewarding scarcity, hard assets, strategic infrastructure, and select company-specific upside.

That is a healthier message than most people realize.

Yes, we are still in a tape shaped by war headlines, elevated oil, and unresolved inflation pressure. But the leadership did not hide only in bond proxies or consumer staples. It went into aluminum, gold, silver, exploration and production, orbital infrastructure, biotech catalysts, and selective squeeze names.

That tells me money is still trying to get ahead of the next shortage, the next bottleneck, and the next supply-driven repricing.

In other words, the tape is still offering opportunity, but it is demanding selectivity.

This is where the report gets more interesting.

The average insider buy/sell ratio at 0.34 says insiders broadly are still constructive.

But the more important question is where that conviction is showing up.

And this week, insider activity starts to line up with the winning themes in a way that could matter over the next few weeks, not just the next few days.

One of the strongest overlaps sits in a biotech name that just saw an $8.7 million director buy. That matters because biotech was already one of the week’s strongest areas, and director-level money of that size is not casual. It is a signal worth respecting.

Another overlap sits inside the metals trade, where a precious-metals name saw multiple insider purchases from officers and directors. That is exactly the kind of confirmation I like to see when the broader tape is already rewarding scarce-material exposure.

This is the distinction that matters for subscribers.

Anybody can look backward and tell you what already went up.

What we want are the names where insider conviction is showing up in the same themes the market just told us it cares about.

That is where the next actionable ideas tend to come from.

If you are managing this market in real time, I would keep the watchlist centered on six areas:

Metals and miners, especially names with direct aluminum, gold, and silver leverage.
Biotech, but only where there is either a fresh catalyst or real insider sponsorship.
Defense and space, especially if the secondary names keep following through.
Energy and power infrastructure, particularly where tight supply can keep margins firm.
Communications and satellite-linked infrastructure.
Selective rate-sensitive laggards, but only as trades, not long-term core positions.

The common denominator is simple: this market is rewarding assets and businesses tied to scarcity, resilience, and strategic importance.

That is the map.

Now comes the part that matters most.

This is where the story gets more actionable.

This section shows you where insiders are beginning to confirm that move.

That matters because the best setups usually come when market leadership and insider conviction start pointing in the same direction. Not every winning theme had insider confirmation this week. But a few names stood out, and the ones that did are worth paying close attention to.

Here are the 5 names I think matter most right now.